mstockstill on DSK4VPTVN1PROD with NOTICES


68460 Federal Register / Vol. 76, No. 214 / Friday, November 4, 2011 / Notices 

addition to the Special Exposure Cohort 

(SEC) under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. On October 18, 

2011, the Secretary of HHS designated 

the following class of employees as an 

addition to the SEC: 

All Atomic Weapons Employees who 

worked at Vitro Manufacturing in 

Canonsburg, Pennsylvania, from January 1, 

1960 through September 30, 1965, for a 

number of work days aggregating at least 250 

work days, occurring either solely under this 

employment or in combination with work 

days within the parameters established for 

one or more other classes of employees in the 

Special Exposure Cohort. 

This designation will become 

effective on November 17, 2011, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 4676 Columbia Parkway, MS C– 

46, Cincinnati, OH 45226, Telephone 

(877) 222–7570. Information requests 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2011–28574 Filed 11–3–11; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from the Ames Laboratory at 

Iowa State University as an addition to 

the Special Exposure Cohort (SEC) 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. On October 18, 

2011, the Secretary of HHS designated 

the following class of employees as an 

addition to the SEC: 

All Department of Energy (DOE) 

employees, its predecessor agencies, and its 

contractors and subcontractors who worked 

in any area of the Ames Laboratory at Iowa 

State University during the period from 

August 13, 1942 through December 31, 1970, 

for a number of work days aggregating at least 

250 work days, occurring either solely under 

this employment or in combination with 

work days within the parameters established 

for one or more classes of employees 

included in the Special Exposure Cohort. 

This designation will become 

effective on November 17, 2011, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 4676 Columbia Parkway, MS C– 

46, Cincinnati, OH 45226, Telephone 

(877) 222–7570. Information requests 

can also be submitted by Email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2011–28575 Filed 11–3–11; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Jayant Jagannathan, M.D., University 

of Virginia Medical Center: Based on the 

report of an investigation conducted by 

the University of Virginia (UVA) and 

additional analysis conducted by ORI in 

its oversight review, ORI found that Dr. 

Jayant Jagannathan, former Resident 

Physician at UVA Medical Center, 

engaged in research misconduct by 

plagiarizing research supported by 

National Institutes of Health (NIH) 

research and training awards and by 

NIH intramural research funds from the 

National Institute of Neurological 

Disorders and Stroke (NINDS), Surgical 

Neurosurgery Branch (NSB), and from 

the National Institute of Dental and 

Craniofacial Research (NIDCR). 

ORI found that the Respondent 

engaged in research misconduct by 

including, in five publications, large 

amounts of text and an illustration that 

he plagiarized from publications 

supported by the following NIH grant 

awards: T32 CA09677, P01 HL024136, 

R01 HL059157, P50 CA090270, M01 

RR01346, R01 CA075979, R01 

DK064169, R01 NS027544, R01 

NS052406, and K08 NS002197,1 and by 

intramural funds from the Surgical 

Neurosurgery Branch, NINDS, and from 

NIDCR. 

Publications in which Respondent 

reported plagiarized material were: 

1. Jagannathan, J., Li, J., Szerlip, N., 

Vortmeyer, A.O., Lonser, R.R., Oldfied, E.H., 

Zhuang, Z. ‘‘Application and implementation 

of selective tissue microdissection and 

proteomic profiling in neurological disease.’’ 

Neurosurgery 64:4–14, 2009 (to be retracted); 

2. Jagannathan, J., Prevedello, D.M., 

Dumont, A.S., Laws, E.R. ‘‘Cellular Signaling 

Molecules as Therapeutic Targets in the 

Treatment of Glioblastoma Multiforme.’’ 

Neurosurgical Focus 20(4):E8, 2006 (retracted 

‘‘due to plagiarism,’’ Neurosurgical Focus 

30(2):E8r, 2011); 

3. Kanter, A.S., Jagannathan, J., Shaffrey, 

C.I., Ouellet, J.A., Mummaneni, P.V. 

‘‘Inflammatory and dysplastic lesions 

involving the spine.’’ Neurosurgical Clinics 

of North America 19(1):93–109, 2008; 

4. Jagannathan, J., Dumont, A.S., 

Prevedello, D.M., Oskouian, R.J., Lopes, B., 

Jane, J.A. Jr, Laws, E.R. Jr. ‘‘Genetics of 

pituitary adenomas: Current theories and 

future implications.’’ Neurosurgical Focus 

19(5):E4, 2005 (retracted ‘‘due to plagiarism,’’ 

Neurosurgical Focus 30(2):E4r, 2011); 

5. Jagannathan, J. ‘‘Role of calcium influx 

and modulation of local neurotransmitters as 

hallmarks of pediatric traumatic brain 

injury.’’ Biomarkers Med. 3:95–97, 2009 

(retracted online 9/11/2010). 

Dr. Jagannathan has entered into a 

Voluntary Settlement Agreement 

(Agreement) and has voluntarily agreed 

for a period of four (4) years, beginning 

on October 20, 2011: 

(1) To have his research supervised; 

Respondent agreed to ensure that prior 

to the submission of an application for 

U.S. Public Health Service (PHS) 

support for a research project on which 

his participation is proposed and prior 

1 T32 CA09677, Radiation Biology Training 

Grant,’’ A. Kennedy, P.I. 

P01 HL024136, ‘‘Mechanisms of Remodeling in 

Chronic Airway Inflammation,’’ G. Caughey, P.I. 

HL059157, ‘‘Angioproteins in Airway Vascular 

Leak and Angiogenesis,’’ D. McDonald, P.I. 

P50 CA090270, ‘‘UTMDACC Cancer Center 

SPORE in prostate cancer,’’ C. Logothetis, P.I. 

M01 RR01346, ‘‘UTHSC GCRC,’’ R. Clark, P.I. 

R01 CA075979, ‘‘Mechanisms for Pituitary 

Tumorigenesis,’’ S. Melmed, P.I. 

R01 DK064169, ‘‘Metabolic Consequences of 

Sccurin Disruption,’’ S. Melmed, P.I. 

R01 NS027544, ‘‘Loss of Developmental Plasticity 

after Head Injury,’’ D.A. Hovda, P.I. 

R01 NS052406, ‘‘Age-dependent Ketone 

Metabolism after Brain Injury,’’ M.L. Prims, P.I. 

K08 NS002197, ‘‘NMDA Receptor Dysfunction 

after Traumatic Brain Injury,’’ C.C. Christopher, P.I.